In fact, the search of the Cancer Genome Atlas (TCGA) database revealed that AML samples with high expression of Evi1 were significantly associated with low expression of EZH2, indicating a cooperative role of overexpression of Evi1 and impaired function of PRC2 in the development of AML (manuscript in submission). This evidence concerns the gene RUNX1 and acute myeloid leukemia.